4.7 Article

EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome

期刊

BLOOD
卷 134, 期 3, 页码 277-290

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2018893404

关键词

-

资金

  1. Swedish Research Council [2014-06807]
  2. INSERM
  3. Ligue Nationale contre le Cancer (Equipe Labellisee La Ligue)
  4. GIS-Institut des maladies rares
  5. Agence Nationale de la Recherche under Investissements d'avenir program [ANR-10-IAHU-01]
  6. Bloodwise [12048]
  7. UK Medical Research Council [MC_ U105161083, MC_UP_A390_1106, 1330931]
  8. Wellcome Trust [100140]
  9. Medical Research Council
  10. Connor Wright Shwachman Diamond Project
  11. Cambridge National Institute for Health Research Biomedical Research Centre
  12. MRC [MR/L003368/1, MC_UP_A390_1106, MC_U105161083] Funding Source: UKRI
  13. Swedish Research Council [2014-06807] Funding Source: Swedish Research Council

向作者/读者索取更多资源

Shwachman-Diamond syndrome (SDS) is a recessive disorder typified by bone marrow failure and predisposition to hematological malignancies. SDS is predominantly caused by deficiency of the allosteric regulator Shwachman-Bodian-Diamond syndrome that cooperates with elongation factor-like GTPase 1 (EFL1) to catalyze release of the ribosome antiassociation factor eIF6 and activate translation. Here, we report biallelic mutations in EFL1 in 3 unrelated individuals with clinical features of SDS. Cellular defects in these individuals include impaired ribosomal subunit joining and attenuated global protein translation as a consequence of defective eIF6 eviction. In mice, Efl1 deficiency recapitulates key aspects of the SDS phenotype. By identifying biallelic EFL1 mutations in SDS, we define this leukemia predisposition disorder as a ribosomopathy that is caused by corruption of a fundamental, conserved mechanism, which licenses entry of the large ribosomal subunit into translation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据